BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Business

  Anti-Addiction Groups Call For FDA Commissioner To Step Down

  September 24, 2014

   · 

  1 min read
• Business

  Innovus Pharma Strikes $171.25 Million Zestra Deal With Sothema Laboratories

  September 24, 2014

   · 

  5 min read
• ProQR Therapeutics B.V. Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Shares

  September 24, 2014

   · 

  2 min read
• Drug Development

  Egalet Announces Update On Clinical Development Plan For Abuse-Deterrent Morphine Egalet-001

  September 24, 2014

   · 

  5 min read
• Drug Development

  ZS Pharma Announces Positive Top-Line Results From HARMONIZE (ZS004), A Second Phase 3 Clinical Trial Of ZS-9 In Patients With Hyperkalemia

  September 24, 2014

   · 

  6 min read
• Drug Development

  Lipocine Inc. To Host Conference Call And Webcast To Discuss Top-Line Results From The Phase 3 Study Of LPCN 1021

  September 24, 2014

   · 

  2 min read
• Deals

  Foamix Pharmaceuticals, Ltd. Announces Closing Of Initial Public Offering

  September 24, 2014

   · 

  3 min read
• Biotech Bay

  Hyperion Therapeutics To Host Analyst Day September 30, 2014

  September 24, 2014

   · 

  1 min read
• Genetown

  Agios Pharmaceuticals To Present At The 2014 Leerink Partners Rare Disease Roundtable

  September 24, 2014

   · 

  3 min read
• Drug Development

  MediciNova, Inc. Provides Update On Phase 2b Trial Of MN-166 (Ibudilast) In Progressive MS

  September 24, 2014

   · 

  8 min read